Clinicopathologic features of poorly differentiated hepatocellular carcinoma

Journal of Surgical Oncology

Volumn 95, Issue 4, 2007, Pages 311-316

  Oishi, Koichi ^a   Itamoto, Toshiyuki ^a   Amano, Hironobu ^a   Fukuda, Saburo ^a   Ohdan, Hideki ^a   Tashiro, Hirotaka ^a   Shimamoto, Fumio ^b   Asahara, Toshimasa ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Liver transplantation; Prognostic factor; Tumor differentiation

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33847634740     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20661     Document Type: Article

References (39)

1. Castells A, Bruix J, Bru C, et al.: Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993;18:1121-1126.
2. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire: A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1256-1261.
3. Arii S, Yamaoka Y, Futagawa S, et al.: Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan Hepatology 2000;32:1224-1229.
4. Mazzaferro V, Regalia E, Doci R, et al.: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
5. Figueras J, Jaurrieta E, Valls C, et al.: Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: A comparative study. Hepatology 1997;25: 1485-1489.
6. Marsh JW, Dvorchik I, Bonham CA, et al.: Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000;88:538-543.
7. Yao FY, Ferrell L, Bass NM, et al.: Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403.
8. Yao FY, Ferrell L, Bass NM, et al.: Liver transplantation for hepatocellular carcinoma: Comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002;8:765-774.
9. Tamura S, Kato T, Berho M, et al.: Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 2001;136:25-30; discussion 31.
10. De Carlis L, Giacomoni A, Lauterio A, et al.: Liver transplantation for hepatocellular cancer: Should the current indication criteria be changed? Transpl Int 2003;16:115-122.
11. Hemming AW, Cattral MS, Reed AI, et al.: Liver transplantation for hepatocellular carcinoma. Ann Surg 2001;233:652-659.
12. Esnaola NF, Lauwers GY, Mirza NQ, et al.: Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 2002;6:224-232; discussion 232.
13. Zavaglia C, De Carlis L, Alberti AB, et al.: Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005;100:2708-2716.
14. Todo S, Furukawa H: Living donor liver transplantation for adult patients with hepatocellular carcinoma: Experience in Japan. Ann Surg 2004;240:451-459; discussion 459-461.
15. Akamatsu M, Ishikawa T, Shiratori Y, et al.: Factors predisposing to poorly differentiated hepatocellular carcinoma and its recurrence. Hepatogastroenterology 2005;52:391-397.
16. Liver Cancer Study Group of Japan. "Classification of Primary Liver Cancer". Tokyo: Kanehara & Co., 1997.
17. Edmondson HA, Steiner PE: Primary carcinoma of the liver: A study of 100 cases among 48,900 necropsies. Cancer 1954;7: 462-503.
18. Couinaud C: "Le foie: etudes anatomiques et chirurgicales". Paris: Masson, 1957.
19. Itamoto T, Katayama K, Nakahara H, et al.: Autologous blood storage before hepatectomy for hepatocellular carcinoma with underlying liver disease. Br J Surg 2003;90:23-28.
20. Arii S, Tanaka J, Yamazoe Y, et al.: Predictive factors for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy. Cancer 1992;69:913-919.
21. Ikeda K, Saitoh S, Tsubota A, et al.: Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993;71:19-25.
22. Imamura H, Matsuyama Y, Tanaka E, et al.: Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003;38: 200-207.
23. Belghiti J, Panis Y, Forges O, et al.: Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991;214:114-117.
24. Nagasue N, Uchida M, Makino Y, et al.: Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993;105:488-494.
25. Chen MF, Hwang TL, Jeng LB, et al.: Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch Surg 1994; 129:738-742.
26. Balsells J, Charco R, Lazaro JL, et al.: Resection of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 1996;83:758-761.
27. Michel J, Suc B, Montpeyroux F, et al.: Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol 1997;26:1274-1280.
28. Poon RT, Fan ST, Lo CM, et al.: Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: Implications for a strategy of salvage transplantation. Ann Surg 2002;235:373-382.
29. Llovet JM, Fuster J, Bruix J: Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology 1999;30:1434-1440.
30. Gleason DF, Mellinger GT: Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.
31. Colella G, Rondinara GF, De Carlis L, et al.: Liver transplantation for hepatocellular carcinoma: Prognostic factors associated long-term survival. Transpl Int 1996;9:S109-111.
32. Jonas S, Bechstein WO, Steinmuller T, et al.: Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001;33:1080-1086.
33. Endo K, Ueda T, Ueyama J, et al.: Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: Relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum Pathol 2000;31:558-565.
34. Matsumura M, Niwa Y, Kato N, et al.: Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: A possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994;20: 1418-1425.
35. Funaki N, Tanaka J, Seto S, et al.: Highly-sensitive identification of alpha-fetoprotein mRNA in circulating peripheral blood of hepatocellular carcinoma patients. Life Sci 1995;57:1621-1631.
36. Lemoine A, Le Bricon T, Salvucci M, et al.: Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery. Ann Surg 1997;226:43-50.
37. Kienle P, Weitz J, Klaes R, et al.: Detection of isolated disseminated tumor cells in bone marrow and blood samples of patients with hepatocellular carcinoma. Arch Surg 2000;135: 213-218.
38. Waguri N, Suda T, Nomoto M, et al.: Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation. Clin Cancer Res 2003;9:3004-3011.
39. Takamori R, Wong LL, Dang C, Wong L: Needle-tract implantation from hepatocellular cancer: Is needle biopsy of the liver always necessary? Liver Transpl 2000;6:67-72.